Overview
- Researchers applied advanced genetic sequencing to 52 plasma samples originally collected for cardiovascular risk studies.
- The multicancer early detection test flagged tumor-derived material in eight participants up to three years before clinical diagnosis.
- Yuxuan Wang said earlier detection could catch tumors at less advanced, more treatable stages.
- Nickolas Papadopoulos emphasized the need to establish follow-up protocols for individuals with positive early detection results.
- Experts call for larger trials to confirm the test’s reliability across cancer types and its potential to lower mortality rates.